Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Serkan Demirci"'
Autor:
Gülin Alkan Şen, Esra Aydın, Murad Guliyev, Nihan Şentürk Öztaş, Ezgi Değerli, Nebi Serkan Demirci, Zeynep Hande Turna, Fuat Hulusi Demirelli
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background The HER-2 status of breast cancer (BC) has been classified as negative or positive for a long time. Given the efficacy of novel anti-HER2-targeted antibody drug conjugates (ADCs) in HER2-low BC, a distinct subgroup of HER2-low tum
Externí odkaz:
https://doaj.org/article/98931270611d484a8f3f578cc960f2b5
Autor:
Serkan Demirci
Publikováno v:
Polymers, Vol 10, Iss 9, p 956 (2018)
Crosslinked-polymer brushes give rise to new opportunities for functionalizing, protecting, and structuring both organic and inorganic materials. In this study, pH- and temperature-switchable crosslinked-polymer brushes were easily prepared by combin
Externí odkaz:
https://doaj.org/article/d44e474871764f0ca4fba0aa3dd1cdaf
Autor:
Barış EKİNCİ, Nebi Serkan DEMİRCİ
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 11, Iss 4, Pp 385-394 (2023)
Aim: The desired survival times could not be achieved with conventional treatments in lung cancer. Tyrosine kinase inhibitors (TKIs) are used in the treatment of non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR)
Externí odkaz:
https://doaj.org/article/0d738e0a8af644319502ac697d5c4429
Autor:
Nebi Serkan Demirci, Eyyup Cavdar, Nuriye Yildirim Ozdemir, Sinemis Yuksel, Yakup Iriagac, Gokmen Umut Erdem, Hatice Odabas, Ilhan Hacibekiroglu, Mustafa Karaagac, Mahmut Ucar, Banu Ozturk, Yakup Bozkaya
Publikováno v:
Medicina, Vol 60, Iss 5, p 818 (2024)
Background and Objectives: In ampullary cancer, 5-year survival rates are 30–50%, even with optimal resection and perioperative systemic therapies. We sought to determine the important clinicopathological features and adjuvant treatments in terms o
Externí odkaz:
https://doaj.org/article/8626dfe6c0064ba792f099060c6a66fb
Autor:
Emir ÇELİK, Muhammed Şamil ASLAN, Nilay ŞENGÜL SAMANCI, Mehmet KARADAĞ, Veysel SUZAN, Yasemin ÇAKAN ÇELİK, Nebi Serkan DEMİRCİ, Fuat Hulusi DEMİRELLİ
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 9, Iss 1, Pp 84-90 (2021)
Aim:Malnutrition is one of the most common clinical problems in cancer patients. Its frequency increases in hospitalized cancer patients. In this study, it was aimed to investigate the frequency of malnutrition and its effect on quality of life (QOL)
Externí odkaz:
https://doaj.org/article/b11ffa8bb28843cbbc507cf9d66e352f
Autor:
Muhammet Bekir Hacioglu, Bulent Erdogan, Murat Bardakcı, Efnan Algın, Burcu Gulbagcı, Ilhan Hacibekiroglu, Jamshid Hamdard, Omer Fatih Olmez, Hadi Akkus, Berna Oksuzoglu, Sema Sezgin Goksu, Shute Ailia Dae, Ahmet Taner Sumbul, Muzaffer Ugraklı, Mustafa Karaagac, Elif Sahin, Devrim Cabuk, Ozden Ozer, Tugba Yavuzsen, Rukiye Arıkan, Osman Köstek, Muhammed Mustafa Atcı, Abdullah Sakin, Adem Deligonul, Duygu Bayır, Murat Dincer, Oktay Unsal, Ozan Yazıcı, Esra Zeynelgil, Ahmet Gulmez, Hakan Harputluoglu, Cihan Erol, Mehmet Ali Nahit Sendur, Aydin Aytekin, Baran Akagunduz, Irem Oner, Ozlem Er, Bugra Oztosun, Mahmut Gumus, Fatih Selcuk Biricik, Musa Baris Aykan, Nuri Karadurmus, Ezgi Degerli, Nebi Serkan Demirci, Esma Turkmen, Teoman Şakalar, Saban Secmeler, Ozgur Tanrıverdi, Ali Alkan, Yasemin Kemal, Ibrahim Cil, Caglar Unal, Yakup Iriagaç, Ozkan Alan, Sevinc Balli, Yuksel Urun, Erkan Ozcan, Nazım Serdar Turhal, Irfan Cicin
Publikováno v:
Head & Neck.
Background: Most of the studies on salivary gland cancers are limited for various reasons such as being single-center, small number of patients, including only major or minor SGCs, or only including epidemiological data. Methods: A total of 37 medica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79529589697c134a903b09e8faaa6c1f
https://doi.org/10.1002/hed.27376
https://doi.org/10.1002/hed.27376
Autor:
Pınar Gursoy, Ali Murat Tatli, Dilek Erdem, Erdem Goker, Emir Celik, Nebi Serkan Demirci, Abdullah Sakin, Muhammed Mustafa Atci, Ertuğrul Bayram, Tuğba Akın Telli, Burak Bilgin, Ahmet Bilici, Baran Akangunduz, Sevinç Balli, Ahmet Demirkazik, Fatih Selçukbiricik, Serkan Menekse, Eyyüp Cavdar, Akın Ozturk, Esma Türkmen Bekmez, Serdal Turhal, Sadettin Kilickap, Hasan Çağrı Yildirim, Başak Oyan, Asude Aksoy, Fatma Paksoy Turkoz, Engin Kut, Nuran Katgi, Teoman Sakalar, Murat Akyol, Halil İbrahim Ellez, Atakan Topcu, Atike Pınar Erdoğan, Kezban Nur Pilanci, Engin Hedem, Hacı Arak, Nadiye Akdeniz, Özkan Alan, Burcu Yapar, Deniz Nart, Perran Fulden Yumuk
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 149:865-875
Objectives: To compare the survival of first- and second-generation tyrosine kinase inhibitors (TKIs) in patients with rare EGFR exon 18 and exon 20 mutation-positive non-small cell lung cancer (NSCLC). Materials and methods: We retrospectively evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6dfec0cbcbdd9f35f252256f8357168
https://doi.org/10.1007/s00432-022-03984-5
https://doi.org/10.1007/s00432-022-03984-5
Autor:
Ezgi Değerli, Nihan Şentürk Öztaş, Gülin Alkan, Şahin Bedir, Sümeyra Derin, Nahıda Valıkhanova, Betül Saraç, Ezgi Kacar, Nebi Serkan Demirci, Hulusi Fuat Demirelli, Hande Turna
Publikováno v:
Journal of Chemotherapy. 35:29-38
Majority of patients with breast cancer were diagnosed with locally advanced stages of the disease (54%). This study aimed to explain the pathological response received to neoadjuvant chemotherapy (NACT) according to the molecular classification of b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b431ec75ecbc9a1f73275308a4cbe3c9
https://doi.org/10.1080/1120009x.2022.2043514
https://doi.org/10.1080/1120009x.2022.2043514
Autor:
Mehmet Karadag, Aysegul Akkan Suzan, Nilay Sengul Samanci, Fuat Demirelli, Hakan Yavuzer, Alper Döventaş, Emir Celik, Serdar Sahin, Muhammed Samil Aslan, Nebi Serkan Demirci, Veysel Suzan
Publikováno v:
European Geriatric Medicine. 13:267-274
Introduction In 2019, The EWGSOP2 group made updates on the definition and diagnosis of sarcopenia. The aim of this study is to determine the possible risk factors for chemotherapy dose-limiting toxicity (DLT). Methods Newly diagnosed gastrointestina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55e465841907844a5d0d70eeeed9f53d
https://doi.org/10.1007/s41999-021-00592-3
https://doi.org/10.1007/s41999-021-00592-3
Publikováno v:
ChemistrySelect
Polycaprolactone (PCL) nanofibers incorporating azo dye/γ-cyclodextrin inclusion complex (Azo/γ-CD-IC) were successfully produced. The characteristics of the Azo/γ-CD-IC and PCL/Azo/γ-CD-IC nanofibers were investigated by X-ray diffraction (XRD),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7bf331618d4477f40111bd411b26433
https://doi.org/10.1002/slct.202101881
https://doi.org/10.1002/slct.202101881